Two impressive studies in lung cancer and another in breast cancer made Sunday a stellar day for AstraZeneca at the ASCO congress. Three of the group’s top cancer drugs were on display – EGFR ...
The ASCO guideline for locally advanced rectal cancer includes patients with T3 or T4 and/or node-positive disease. Patients with T3 tumors with magnetic resonance imaging (MRI)–assessed extramural ...